RYBELSUS is contraindicated in patients with a prior serious hypersensitivity reaction to semaglutide or to any of the excipients in RYBELSUS [see Adverse Reactions (6.2)]
During treatment, most people eat less without actively trying, which leads to early weight loss and, for many, a noticeable reduction in preoccupation with food
With Wegovy, you might also experience more severe stomach-related issues
Healthcare providers screen for contraindications, such as a family history of thyroid cancer, MEN2, or pancreatitis, and perform essential lab tests like A1C, TSH, metabolic panels, and lipid profiles before starting treatment